Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices

References

1. ↵
   Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43–66.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Ransohoff DF, McNaughton Collins M, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med 2002; 113: 663–7.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003; 289: 1414–20.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Screening for prostate cancer. American College of Physicians. Ann Intern Med 1997; 126: 480–4.

   OpenUrlCrossRefPubMedWeb of Science
5. Carroll P, Coley C, McLeod D, et al. Prostate-specific antigen best practice policy–part I: early detection and diagnosis of prostate cancer. Urology 2001; 57: 217–24.

   OpenUrlCrossRefPubMedWeb of Science
6. Ferrini R, Woolf SH. American College of Preventive Medicine practice policy. Screening for prostate cancer in American men. Am J Prev Med 1998; 15: 81–4.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer, 2005. CA Cancer J Clin 2005; 55: 31–44.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   US Preventive Services Task Force. Screening for prostate cancer: recommendation and rationale. Ann Intern Med 2002; 137: 915–6.

   OpenUrlPubMedWeb of Science
9. ↵
   Austin OJ, Valente S, Hasse LA, Kues JR. Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians. Arch Fam Med 1997; 6: 453–8.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Konety BR, Sharp VJ, Verma M, Williams RD. Practice patterns in screening and management of prostate cancer in elderly men. Urology 2006; 68: 1051–6.

    OpenUrlPubMed
11. ↵
    Edlefsen KL, Mandelson MT, McIntosh MW, Andersen MR, Wagner EH, Urban N. Prostate-specific antigen for prostate cancer screening. Do physician characteristics affect its use? Am J Prev Med 1999; 17: 87–90.

    OpenUrlCrossRefPubMedWeb of Science
12. Hoffman RM, Papenfuss MR, Buller DB, Moon TE. Attitudes and practices of primary care physicians for prostate cancer screening. Am J Prev Med 1996; 12: 277–81.

    OpenUrlPubMedWeb of Science
13. Lawson DA, Simoes EJ, Sharp D, et al. Prostate cancer screening–a physician survey in Missouri. J Community Health 1998; 23: 347–58.

    OpenUrlCrossRefPubMedWeb of Science
14. Purvis Cooper C, Merritt TL, Ross LE, John LV, Jorgensen CM. To screen or not to screen, when clinical guidelines disagree: primary care physicians’ use of the PSA test. Prev Med 2004; 38: 182–91.

    OpenUrlCrossRefPubMedWeb of Science
15. Voss JD, Schectman JM. Prostate cancer screening practices and beliefs [see comment]. J Gen Intern Med 2001; 16: 831–7.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    Han PK, Coates RJ, Uhler RJ, Breen N. Decision making in prostate-specific antigen screening National Health Interview Survey, 2000. Am J Prev Med 2006; 30: 394–404.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    Carlos RC, Underwood W 3rd, Fendrick AM, Bernstein SJ. Behavioral associations between prostate and colon cancer screening. J Am Coll Surg 2005; 200: 216–23.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    Moran WP, Cohen SJ, Preisser JS, Wofford JL, Shelton BJ, McClatchey MW. Factors influencing use of the prostate-specific antigen screening test in primary care. Am J Manag Care 2000; 6: 315–24.

    OpenUrlPubMedWeb of Science
19. ↵
    Williams RB, Boles M, Johnson RE. Use of prostate-specific antigen for prostate cancer screening in primary care practice [see comment]. Arch Fam Med 1995; 4: 311–5.

    OpenUrlCrossRefPubMed
20. Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J. Racial differences in screening for prostate cancer in the elderly. Arch Intern Med 2004; 164: 1858–64.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    Lu-Yao G, Stukel TA, Yao SL. Prostate-specific antigen screening in elderly men. J Natl Cancer Inst 2003; 95: 1792–7.

    OpenUrlAbstract/FREE Full Text
22. Lu-Yao GL, Barry MJ, Albertsen PC, Yao SL. Outcomes of treatment vs observation of localized prostate cancer in elderly men. JAMA 2007; 297: 1651; author reply 1652–3.

    OpenUrlCrossRefPubMed
23. ↵
    Yao SL, Lu-Yao G. Understanding and appreciating overdiagnosis in the PSA era. J Natl Cancer Inst 2002; 94: 958–60.

    OpenUrlFREE Full Text
24. ↵
    US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 185–91.

    OpenUrlCrossRefPubMedWeb of Science
25. ↵
    Fall K, Garmo H, Andren O, et al. Prostate-specific antigen levels as a predictor of lethal prostate cancer. J Natl Cancer Inst 2007; 99: 526–32.

    OpenUrlAbstract/FREE Full Text
26. ↵
    Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352: 1977–84.

    OpenUrlCrossRefPubMedWeb of Science
27. Wong YN, Mitra N, Hudes G, et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 2006; 296: 2683–93.

    OpenUrlCrossRefPubMedWeb of Science
28. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347: 781–9.

    OpenUrlCrossRefPubMedWeb of Science
29. ↵
    Lu-Yao GL, Friedman M, Yao SL. Use of radical prostatectomy among Medicare beneficiaries before and after the introduction of prostate specific antigen testing. J Urol 1997; 157: 2219–22.

    OpenUrlCrossRefPubMedWeb of Science
30. ↵
    Kerfoot BP, Holmberg EF, Lawler EV, Krupat E, Conlin PR. Practitioner-level determinants of inappropriate prostate-specific antigen screening. Arch Intern Med 2007; 167: 1367–72.

    OpenUrlCrossRefPubMedWeb of Science
31. ↵
    Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA 2006; 296: 2336–42.

    OpenUrlCrossRefPubMedWeb of Science
32. ↵
    Scales CD, Jr., Curtis LH, Norris RD, Schulman KA, Albala DM, Moul JW. Prostate specific antigen testing in men older than 75 years in the United States. J Urol 2006; 176: 511–4.

    OpenUrlCrossRefPubMedWeb of Science
33. ↵
    Draisma G, Boer R, Otto SJ, et al. Lead times and Overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003; 95: 868–78.

    OpenUrlAbstract/FREE Full Text
34. ↵
    Dickey LL, Kamerow DB. Primary care physicians’ use of office resources in the provision of preventive care. Arch Fam Med 1996; 5: 399–404.

    OpenUrlCrossRefPubMedWeb of Science
35. ↵
    Dietrich AJ, Carney PA, Winchell CW, Sox CH, Reed SC. An office systems approach to cancer prevention in primary care. Cancer Pract 1997; 5: 375–81.

    OpenUrlPubMed
36. Hudson SV, Ohman-Strickland P, Cunningham R, Ferrante JM, Hahn K, Crabtree BF. The effects of teamwork and system support on colorectal cancer screening in primary care practices. Cancer Detect Prev 2007; 31: 417–23.

    OpenUrlCrossRefPubMedWeb of Science
37. Dietrich AJ, O'Connor GT, Keller A, Carney PA, Levy D, Whaley FS. Cancer: improving early detection and prevention. A community practice randomised trial. BMJ 1992; 304: 687–91.

    OpenUrlAbstract/FREE Full Text
38. ↵
    Jaen CR, McIlvain H, Pol L, Phillips RL Jr, Flocke S, Crabtree BF. Tailoring tobacco counseling to the competing demands in the clinical encounter. J Fam Pract 2001; 50: 859–63.

    OpenUrlPubMedWeb of Science
39. Jaen CR, Stange KC, Nutting PA. Competing demands of primary care: a model for the delivery of clinical preventive services. J Fam Pract 1994; 38: 166–71.

    OpenUrlPubMedWeb of Science
40. Jaen CR, Stange KC, Tumiel LM, Nutting P. Missed opportunities for prevention: smoking cessation counseling and the competing demands of practice. J Fam Pract 1997; 45: 348–54.

    OpenUrlPubMedWeb of Science
41. ↵
    Carney PA, Dietrich AJ, Keller A, Landgraf J, O'Connor GT. Tools, teamwork, and tenacity: an office system for cancer prevention. J Fam Pract 1992; 35: 388–94.

    OpenUrlPubMedWeb of Science
42. Carpiano RM, Flocke SA, Frank SH, Stange KC. Tools, teamwork, and tenacity: an examination of family practice office system influences on preventive service delivery. Prev Med 2003; 36: 131–40.

    OpenUrlCrossRefPubMedWeb of Science
43. Crabtree BF, Miller WL, Aita VA, Flocke SA, Stange KC. Primary care practice organization and preventive services delivery: a qualitative analysis. J Fam Pract 1998; 46: 403–9.

    OpenUrlPubMedWeb of Science
44. Griffith HM, Rahman MI. Implementing the Put Prevention into Practice program. Nurse Pract 1994; 19: 12, 15–9.

    OpenUrlPubMed
45. Stange KC. One size doesn't fit all. Multimethod research yields new insights into interventions to increase prevention in family practice. J Fam Pract 1996; 43: 358–60.

    OpenUrlPubMedWeb of Science
46. ↵
    Crabtree BF, Miller WL, Stange KC. Understanding practice from the ground up. J Fam Pract 2001; 50: 881–7.

    OpenUrlPubMedWeb of Science
47. ↵
    Stroebel CK, McDaniel RR Jr, Crabtree BF, Miller WL, Nutting PA, Stange KC. How complexity science can inform a reflective process for improvement in primary care practices. Jt Comm J Qual Patient Saf 2005; 31: 438–46.

    OpenUrlPubMed
48. ↵
    Hudson SV, Harris-Haywood S, Stange KC, Orzano AJ, Crabtree BF. Recruiting minority primary care practices into practice-based research. Med Care 2006; 44: 696–700.

    OpenUrlCrossRefPubMedWeb of Science
49. ↵
    Orzano AJ, Scott J, Hudson SV, et al. Strategies for conducting complex clinical trials in diverse community practices. Med Care 2007; 45: 1221–6.

    OpenUrlCrossRefPubMed
50. ↵
    Ohman-Strickland PA, John Orzano A, Nutting PA, et al. Measuring organizational attributes of primary care practices: development of a new instrument. Health Serv Res 2007; 42: 1257–73.

    OpenUrlCrossRefPubMedWeb of Science
51. ↵
    Kawachi MH, Bahnson RR, Barry M, et al. Prostate cancer early detection. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2007; 5: 714–36.

    OpenUrlAbstract
52. ↵
    Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med 2004; 38: 732–44.

    OpenUrlCrossRefPubMedWeb of Science
53. ↵
    Institutes of Medicine. Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, D.C.: National Academy Press; 2001.
54. ↵
    Guerra CE, Jacobs SE, Holmes JH, Shea JA. Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study. J Gen Intern Med 2007; 22: 901–7.

    OpenUrlCrossRefPubMedWeb of Science
55. ↵
    Lamplugh M, Gilmore P, Quinlan T, Cornford P. PSA testing: are patients aware of what lies ahead? Ann R Coll Surg Engl 2006; 88: 284–8.

    OpenUrlCrossRefPubMedWeb of Science
56. ↵
    Krist AH, Woolf SH, Johnson RE. How physicians approach prostate cancer screening before and after losing a lawsuit. Ann Fam Med 2007; 5: 120–5.

    OpenUrlAbstract/FREE Full Text
57. ↵
    Merenstein D. A piece of my mind. Winners and losers. JAMA 2004; 291: 15–6.

    OpenUrlCrossRefPubMedWeb of Science
58. ↵
    American Urological Association. Guideline on the management of benign prostatic hyperplasia (BPH). 2003, updated 2006. Available at http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm. Accessed 18 March 2009.